AlphaFold predicted structure
AIP · O00170

Mean pLDDT
90.9/ 100
Very high
330 residues
Confidence breakdown
- Very high(≥ 90)77%
- Confident(70–90)16%
- Low(50–70)3%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
AHR interacting HSP90 co-chaperone
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Adult solid tumours for rare disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEndocrine neoplasia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedMultiple endocrine tumours
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedAdult solid tumours cancer susceptibility
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownParathyroid Cancer
growth hormone-secreting pituitary adenoma
familial isolated pituitary adenoma
growth hormone secreting pituitary adenoma 1
Inherited cancer-predisposing syndrome
hereditary neoplastic syndrome
pituitary tumor
prolactin-producing pituitary gland adenoma
ACTH-producing pituitary gland adenoma
Cushing syndrome
malignant endocrine neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Small ribosomal subunit protein bS22, mitochondrial
May act as a negative regulator of Aurora-A kinase, by down-regulation through proteasome-dependent degradation
AIP · O00170

Mean pLDDT
90.9/ 100
Very high
330 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0